NIH DP1 Grants — NIH Director's Pioneer Award
Reviewed by Dr. Meng ZhaoLast reviewed June 9, 2026Data refreshed September 5, 2026Editorial standards
High-risk/high-reward research from exceptional individual scientists
Funding
$700,000 direct/year
Duration
5 years
Eligibility
Highly innovative individual scientists
Activity code
DP1
What is the NIH DP1 grant?
The DP1 (Pioneer Award) is part of the NIH Director's High-Risk High-Reward program. It funds individual scientists pursuing exceptionally innovative ideas at any career stage.
Recent DP1 awards from NIH RePORTER
Examples of funded DP1 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on September 5, 2026.
Example DP1 projects from the sample
High-dimensional chemical targeting of multiple neuron types to regulate energy balance
5DP1DK139958-03Mark Andermann · BETH ISRAEL DEACONESS MEDICAL CENTER, MA · $800,000 · awarded Aug 27, 2026 · NIHSummary Recent drugs for treating obesity and diabetes, while promising, have major side effects. For example, drugs that reduce food intake by targeting the melanocortin-4 receptor (MC4R) or the glucagon-like peptide-1 receptor (GLP1R) induce side effects such as nausea and vomiting. Several drugs targeting these receptors likely act in part via effects on…
Immune drivers of oncogenic virus progression to cancer in people living with HIV
5DP1CA290976-02Brittney Dickey · UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE · $544,250 · awarded Aug 24, 2026 · NIHPROJECT SUMMARY/ABSTRACT The overarching goal of my research is to improve prevention, early detection, and outcomes of infection- related cancers, particularly among people living with HIV (PHIV) who experience an increased burden. Due to the immunosuppression and aberrant immune activation that accompanies lifelong HIV infection, PHIV have a higher…
Ultrasound-induced artificial hibernation: Mimicking natural hibernation to enhance human health
4DP1DK143574-03Hong Chen · WASHINGTON UNIVERSITY, MO · $3,265,500 · awarded Aug 21, 2026 · NIHProject Summary/Abstract Hibernation is one of the most remarkable physiological traits observed across a spectrum of animal species. Hibernating mammals reside primarily in a state known as torpor, characterized by lowered metabolism and reduced body temperature to conserve energy and survive harsh conditions. This natural phenomenon has inspired the…
Neural control of rhythmic orofacial movements
4DP1NS142432-03Nuo Li · DUKE UNIVERSITY, NC · $3,381,000 · awarded Aug 20, 2026 · NIHAbstract Major efforts to understand how brain circuits activity gives rise to perception, mental experience, and behavior have broadly advanced our understanding of most of the central nervous system. In contrast, the brainstem circuit that connects the brain to patterned muscle outputs is arguably the least understood. The brainstem also generates rhythms…
Decoding the Logic of Metabolite Pool Size Control
1DP1DK147833-01Matthew Hirschey · DUKE UNIVERSITY, NC · $807,500 · awarded Aug 14, 2026 · NIHDespite decades of progress in metabolomics, understanding what determines metabolite concentrations in cells remains a fundamental unsolved problem. While we can measure thousands of metabolites with unprecedented accuracy, we lack an understanding of the control logic that maintains their precise concentrations, such as keeping blood glucose at 5 mM…
Integrated proteomic and metabolomic biomarker profiling for understanding metabolic syndrome in pregnant women living with HIV on Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir (TLD)
3DP1HD115433-03S3AHIZECHUKWU EKE · JOHNS HOPKINS UNIVERSITY, MD · $32,616 · awarded Aug 13, 2026 · NIHPROJECT ABSTRACT/SUMMARY Effective HIV treatment during pregnancy is critically important, both for the health of women living with HIV (PWHIV) and for prevention of perinatal HIV transmission. In the United States, Nigeria, and globally, Dolutegravir (DTG)- based antiretroviral therapy (ART) is being expanded as part of the preferred 1st-line ART regimen,…
3D printed Houses: Integrating Epidemiology into the Architecture
1DP1ES039886-01Michael Levy · UNIVERSITY OF PENNSYLVANIA, PA · $1,137,500 · awarded Aug 12, 2026 · NIHAmerican children spend around 75% of the day in their homes; exposures in the residence are therefore an extremely important correlate of health and risk of disease. Homes are about to change--3D printing technology is ushering in a new shift in architectural design. Every housing form carries its own particular health risks, which can be greater or lesser…
Re-Engineering Systems to Treat Opioid use Disorder for Everyone (RESTORE): A Pilot Randomized Controlled Trial
5DP1DA058978-03Sabrina Smiley · SAN DIEGO STATE UNIVERSITY, CA · $1,053,500 · awarded Aug 11, 2026 · NIHI am a well-published, early stage medical sociologist proposing to investigate the feasibility, acceptability, and preliminary efficacy of an innovative, multilevel community-engaged opioid use disorder (OUD) treatment intervention. This study will apply my understanding of community needs and OUD, to test a scalable novel intervention in a real world…
Novel technologies to detect disrupted RNA processing events in diabetic islets
1DP1DK147830-01LORI SUSSEL · UNIVERSITY OF COLORADO DENVER, CO · $780,000 · awarded Aug 11, 2026 · NIHSummary/Abstract In both Type 1 and Type 2 diabetes (T1D and T2D), the inability of beta cells to adequately respond and compensate to autoimmune (T1D) or insulin resistant (T2D) conditions is a central feature of each disease. In addition, there are recent reports that islet alpha cells also become defective at the earliest stages of T1D and T2D to…
Peripheral nervous system aging
5DP1AG100833-02ANNE BRUNET · STANFORD UNIVERSITY, CA · $1,078,000 · awarded Aug 10, 2026 · NIHSummary Aging alters the function of every organ. An inherent limitation to our understanding of aging is the complexity of the aging process. Thus, fundamental questions remain entirely unanswered: Are there mechanisms that coordinate organ function and how do they deteriorate with age? Could such mechanisms be restored to promote longevity? Previous work…
Role of social touch and social memory in organizing naked mole-rat colonies
5DP1AT013723-02Ishmail Abdus-Saboor · COLUMBIA UNIV NEW YORK MORNINGSIDE, NY · $1,151,500 · awarded Aug 6, 2026 · NIHProject Summary/Abstract The East African naked mole-rat is arguably the most social animal in the mammalian kingdom, maintaining decades long harmonious communal living with upwards of hundreds of colony members. Most mammals, including humans, are highly social and cooperation during social interactions is a critical component of our daily lives.…
Informing optimal investments along the preconception to postpartum eMTCT continuum
5DP1HD115428-03Horacio Duarte · UNIVERSITY OF MINNESOTA, MN · $539,000 · awarded Aug 4, 2026 · NIHPROJECT SUMMARY/ABSTRACT While expansion of antiretroviral therapy (ART) coverage over the past two decades has significantly decreased mother-to-child, or “vertical,” transmission, progress has stagnated in recent years. To address the remaining 130,000 new infections among children each year, we must take a broader approach, promoting maternal ART…
Funding institutes in the sample
| Institute | Awards | Funding |
|---|---|---|
| NIH | 185 | $160.2M |
Most frequent institutions in the sample
- STANFORD UNIVERSITY — 12 awards
- DUKE UNIVERSITY — 12 awards
- JOHNS HOPKINS UNIVERSITY — 10 awards
- WASHINGTON UNIVERSITY — 8 awards
- UNIVERSITY OF PENNSYLVANIA — 8 awards
- MASSACHUSETTS GENERAL HOSPITAL — 7 awards
- YALE UNIVERSITY — 7 awards
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — 6 awards
Source: NIH RePORTER. Verify any award in the official record by searching its project number. See our data methodology for how this sample is built and its limitations.
Decision guide
Choose DP1 when
Choose DP1 for genuinely high-risk ideas that would be hard to fit into traditional R01 review.
Choose another mechanism when
DP1 is highly competitive — typically <5% success rate. Have a backup R01 plan.
Who applies for DP1
Individual scientists at any career stage with bold, paradigm-shifting ideas. Selection emphasizes the person and idea more than preliminary data.
Compare nearby NIH grant mechanisms
Searchers often land on DP1 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.
Bold, untested ideas from early-stage investigators
Skip the postdoc — direct PhD-to-PI transition
Long, flexible support for productive investigators (one program per lab)
For broad grant lookup, use the NIH grant search to find funded examples by activity code, PI, institution, and award year.
Search tips for DP1
- DP1 awards identify NIH-flagged exceptional individual scientists.
Open NIH NOFOs for DP1
NIH accepts DP1 applications only through a notice of funding opportunity (NOFO). These one is open or opening soon; each page lists due dates, participating institutes, related notices, and the projects NIH funded under it.